跳至主要内容
临床试验/ISRCTN05257682
ISRCTN05257682已完成不适用

The use of aminolaevulinic acid (ALA) and photodynamic therapy (PDT) in the treatment of Barrett's oesophagus

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 0 人开始时间: 2004年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with biopsy proven high grade dysplasia associated with Barrett's oesophagus who would otherwise require oesophagogastrectomy will be offered ALA-induced PDT. Two groups:
  • 1. Patients with high grade dysplasia who will receive PDT followed by surgery if there is no response
  • 2. Patients with low grade dysplasia who are at lower risk of carcinoma will be entered into a controlled trial and followed up by endoscopy to assess the efficacy and duration of any treatment effects.

排除标准

  • Not provided at time of registration

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

相似试验

The use of aminolaevulinic acid (ALA) and... | 临床试验